{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:36:13Z","timestamp":1792506973995,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.clinthera.2018.12.014","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T01:49:00Z","timestamp":1548812940000},"page":"303-313.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study"],"prefix":"10.1016","volume":"41","author":[{"given":"Diana","family":"Brixner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Ermakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Sieradzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Cyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.12.014_bib1","series-title":"Estimates of Diabetes and its Burden in the United States","article-title":"National diabetes statistics report","year":"2017"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2018.12.014_bib2","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2337\/dc09-S301","article-title":"Defining and characterizing the progression of type 2 diabetes","volume":"32","author":"Fonseca","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2018.12.014_bib3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2337\/dc17-1962","article-title":"Global economic burden of diabetes in adults: projections from 2015 to 2030","volume":"41","author":"Bommer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2018.12.014_bib4","series-title":"IDF Diabetes Atlas","year":"2017"},{"key":"10.1016\/j.clinthera.2018.12.014_bib5","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2018.12.014_bib6","doi-asserted-by":"crossref","first-page":"e2858","DOI":"10.1002\/dmrr.2858","article-title":"A\u00a0global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin","volume":"33","author":"Raccah","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clinthera.2018.12.014_bib7","doi-asserted-by":"crossref","first-page":"e000189","DOI":"10.1136\/bmjdrc-2015-000189","article-title":"Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database study","volume":"4","author":"Bonafede","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.clinthera.2018.12.014_bib8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/dom.12225","article-title":"Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections","volume":"16","author":"Riddle","year":"2014","journal-title":"Diabetes Obes Metab"},{"issue":"9950","key":"10.1016\/j.clinthera.2018.12.014_bib9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(14)61037-0","article-title":"Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial","volume":"384","author":"Reznik","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2018.12.014_bib10","first-page":"16","article-title":"Healthcare utilization changes in relation to treatment intensification with insulin aspart in patients with type 2 diabetes. Data from a large US managed-care organization","volume":"13","author":"Aagren","year":"2010","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.clinthera.2018.12.014_bib11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/PPA.S49287","article-title":"Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine","volume":"7","author":"Miao","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.clinthera.2018.12.014_bib12","series-title":"MarketScan Research Databases","author":"Truven Health Analytics","year":"2018"},{"key":"10.1016\/j.clinthera.2018.12.014_bib13","unstructured":"US Dept Health & Human Services. Health insurance portability and accountability Act of 1996. http:\/\/www.hhs.gov\/hipaa\/for-professionals\/privacy\/laws-regulations\/. Accessed July 25, 2018."},{"key":"10.1016\/j.clinthera.2018.12.014_bib14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clinthera.2018.12.014_bib15","unstructured":"Bureau of Labor Statistics. Consumer Price Index: Measuring Price Change for Medical Care in the CPI. https:\/\/www.bls.gov\/cpi\/factsheets\/medical-care.htm. Accessed January 22, 2019."},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2018.12.014_bib16","first-page":"S1","article-title":"Standards of medical care in diabetes\u20142017","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2018.12.014_bib17","unstructured":"Enhancing the quality and transparency of health research (EQUATOR) Network. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. https:\/\/www.equator-network.org\/reporting-guidelines\/cheers\/. Accessed January 22, 2019."},{"key":"10.1016\/j.clinthera.2018.12.014_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jdiacomp.2011.03.005","article-title":"Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic review","volume":"25","author":"Giugliano","year":"2011","journal-title":"J\u00a0Diabetes Complicat"},{"issue":"Suppl 4-a","key":"10.1016\/j.clinthera.2018.12.014_bib19","first-page":"S39","article-title":"Comparison of health resource utilization for multiple daily injections (MDI) with basal and bolus insulin therapy versus non-MDI therapy in patients with type 2 diabetes","volume":"24","author":"Ludden","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.clinthera.2018.12.014_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jdiacomp.2011.01.002","article-title":"The effort required to achieve and maintain optimal glycemic control","volume":"25","author":"Rosenthal","year":"2011","journal-title":"J\u00a0Diabetes Complicat"},{"key":"10.1016\/j.clinthera.2018.12.014_bib21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1464-5491.2012.03605.x","article-title":"Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study","volume":"29","author":"Peyrot","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2018.12.014_bib22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1463-1326.2012.01636.x","article-title":"Factors associated with injection omission\/non-adherence in the global attitudes of patients and physicians in insulin therapy study","volume":"14","author":"Peyrot","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2018.12.014_bib23","first-page":"2297","article-title":"Insulin dosing and outcomes among commercially insured patients with type 2 diabetes in the United States","volume":"37","author":"Eby","year":"2015","journal-title":"Clin\u00a0Ther"},{"key":"10.1016\/j.clinthera.2018.12.014_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2337\/dc09-1348","article-title":"Correlates of insulin injection omission","volume":"33","author":"Peyrot","year":"2010","journal-title":"Diabetes Care"},{"issue":"suppl 4-a","key":"10.1016\/j.clinthera.2018.12.014_bib25","first-page":"S43","article-title":"Evaluating persistence of basal-bolus insulin therapy in type 2 diabetes and its impact on clinical and economic outcomes using retrospective claims data","volume":"24","author":"Ermakova","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.clinthera.2018.12.014_bib26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s13300-015-0138-7","article-title":"Use of V-Go insulin delivery device in patients with sub-optimally controlled diabetes mellitus: a retrospective analysis from a large specialized diabetes system","volume":"6","author":"Lajara","year":"2015","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.clinthera.2018.12.014_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1932296816653143","article-title":"Efficacy of a tubeless patch pump in patients with type 2 diabetes previously treated with multiple daily injections","volume":"11","author":"Layne","year":"2017","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.clinthera.2018.12.014_bib28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/dom.12642","article-title":"Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial","volume":"18","author":"Aronson","year":"2016","journal-title":"Diabetes Obes Metab"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819300013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819300013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T22:03:27Z","timestamp":1552514607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819300013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0149291819300013"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.12.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}